Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans

類似資料

• Recent advances in our understanding of the allograft response
  著者:: Hennessy, C, 等
  出版事項: (2021)
• Immunoregulation: the interplay between metabolism and redox homeostasis
  著者:: E. Perpiñán, 等
  出版事項: (2023-11-01)
• Biomarkers and surrogates of acute rejection in vascularized composite allograft transplantation
  著者:: Honeyman, C, 等
  出版事項: (2021)
• Biomarker and surrogate development in vascularised composite allograft transplantation: current progress and future challenges
  著者:: Honeyman, C, 等
  出版事項: (2020)
• Tissue targeted regulatory T cell therapy prevents human skin allograft rejection in a humanised mouse model
  著者:: Issa, F, 等
  出版事項: (2013)